Kids-EEZE

Product NDC: 61941-1002
11-digit product format: 619411002
Labeler code: 61941
Product ID: 61941-1002_4f391211-f806-4c0f-887b-d32759754a49
Type: HUMAN OTC DRUG
Nonproprietary name: Guaifenesin
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: ORAL
Labeler: ProPhase Labs, Inc.
Application: part341
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2008-09-01
Marketing end: 0000-00-00
Substance: GUAIFENESIN
Active strength: 100 mg/1
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	61941-1002		I	Inactivated by FDA		2026-10-05
excluded package	package	61941-1002	61941-1002-1	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61941-1002-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61941-1002-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61941-1002-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61941-1002-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61941-1002-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61941-1002-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61941-1002-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61941-1002-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61941-1002-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61941-1002-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61941-1002-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61941-1002-1	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	61941-1002-1	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	61941-1002-1	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	61941-1002-1	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	61941-1002-1	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	61941-1002-1	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	61941-1002-1	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	61941-1002-1	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	61941-1002-1	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	61941-1002-1	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	61941-1002-1	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4fe95224-f543-4dbb-9445-8cca122b48c8	Product name	1	20150609
e8718272-64cb-4436-969b-176c3067c8f4	Product name	1	20150609
106ff02a-57e1-4c4c-a307-fd582ff4e311	Product name	1	20150212

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61941-1002-1	2019-10-29	C162847	48780-1	960f7f55-d655-8e05-e053-dbdaa90a074a	Kids-EEZE ® Chest Relief

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61941-1002-1	Kids-EEZE Chest Relief	72 in 1 CASE	TABLET, ORALLY DISINTEGRATING	72		1
61941-1002-6	Kids-EEZE Chest Relief	12 in 1 PACKAGE	TABLET, ORALLY DISINTEGRATING	12		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Guaifenesin	ACTIVE INGREDIENT	495W7451VQ	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
Guaifenesin	ACTIVE MOIETY	495W7451VQ	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
ETHYLCELLULOSE (4 MPA.S)	INACTIVE INGREDIENT	KC5472WRJK	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
ETHYLENE GLYCOL	INACTIVE INGREDIENT	FC72KVT52F	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
LECITHIN, SOYBEAN	INACTIVE INGREDIENT	1DI56QDM62	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
MALIC ACID	INACTIVE INGREDIENT	817L1N4CKP	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2)	INACTIVE INGREDIENT	5KY68S2577	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61941-1002	KIDS-EEZE (GUAIFENESIN) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1	Legacy NDC, 2 package rows	20110601_6f2276fb-7a69-4aae-87f4-8c78e71bfa7b.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
495W7451VQ	GUAIFENESIN	93-14-1	GUAIFENESIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
866449	guaiFENesin 100 MG Chewable Tablet	PSN	6f2276fb-7a69-4aae-87f4-8c78e71bfa7b	1
1111099	Kids-Eeze Chest Relief 100 MG Chewable Tablet	PSN	6f2276fb-7a69-4aae-87f4-8c78e71bfa7b	1
1111099	guaifenesin 100 MG Chewable Tablet [Kids-Eeze Chest Relief]	SBD	6f2276fb-7a69-4aae-87f4-8c78e71bfa7b	1
866449	guaifenesin 100 MG Chewable Tablet	SCD	6f2276fb-7a69-4aae-87f4-8c78e71bfa7b	1
1111099	Kids-Eeze Chest Relief 100 MG Chewable Tablet	SY	6f2276fb-7a69-4aae-87f4-8c78e71bfa7b	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
61941-1002-1	61941100201	72 in 1 CASE	Historical
61941-1002-6	61941100206	12 in 1 PACKAGE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Kids-EEZE ® Chest Relief	ProPhase Labs, Inc. \| Pharmaloz Manufacturing, Inc.	2011-04-01	HUMAN OTC DRUG LABEL	1